Dupilumab 300mg/2ml solution for injection pre-filled syringes
NHS hospitals in England used £61,085,966 of indicative cost of Dupilumab 300mg/2ml solution for injection pre-filled syringes in the 12 months to July 2026, about 0.2% of all hospital medicines spend. That is down 7.5% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Dupilumab 300mg/2ml solution for injection pre-filled syringes: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Dupilumab 300mg/2ml solution for injection pre-filled syringes most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Sheffield Teaching Hospitals Nhs Trust | £6,783,605 |
| Guy's & St Thomas' Nhs Foundation Trust | £4,270,901 |
| South Tees Hosp Nhs Foundation Trust | £4,193,110 |
| Salford Royal Nhs Foundation Trust | £2,529,780 |
| East Sussex Healthcare Nhs Trust | £2,295,143 |
| Royal Cornwall Hospitals Nhs Trust | £2,243,915 |
| Derby Teaching Hospitals Nhs Found Trust | £1,788,554 |
| Lewisham And Greenwich Nhs Trust | £1,711,396 |
| Aintree University Hospital Nhs Ft | £1,495,100 |
| Ashford & St Peter's Hospitals Nhs Ft | £1,196,586 |
The primary-care picture
No confident match to a community-dispensed medicine was found for this product, so no primary-care comparison is shown. SCMD products are recorded at product level, which does not always map cleanly to a BNF substance.